Slovenia · Series B startup

Who invested in GenePlanet

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$34Mraised across 2 rounds since 2018, from 2 sources

$12MRound$22MSeries B
Latest round
Series B, $22MJul 2023
Step-upi
1.9×
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20192020202120222023
$12MRound$22MSeries B
First round
Round, $12M
Jul 2018
Biggest round
$22M
Series B · Jul 2023
Between rounds
5 years
from the last two

The rounds

  1. Jul 2023
    Series B$22M1 new

    Source recorded

  2. Jul 2018
    Round$12M1 new
    • JF Investments AG

    Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2018Series B2023FidelityJF Investments AG

Everyone who backed them

FidelityVC firm1round
JF Investments AGno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about GenePlanet

Who invested in GenePlanet?

GenePlanet's investors include Fidelity and JF Investments AG.

How much has GenePlanet raised?

GenePlanet has raised $34M across 2 rounds since 2018.

When did GenePlanet last raise?

GenePlanet's most recent round was a Series B of $22M in Jul 2023.

What was GenePlanet's biggest round?

Its most recent round, $22M in Jul 2023, is also its largest on record.

Who backed GenePlanet first?

GenePlanet's first round on record, in Jul 2018, was backed by JF Investments AG.

What stage is GenePlanet at?

GenePlanet's latest named round is a Series B, in Jul 2023.

Where is GenePlanet based?

GenePlanet is based in Slovenia.

Companies like GenePlanet

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.